Lucid Diagnostics to Sell 18M Common Shares via Underwriting

Lucid Diagnostics Inc. has entered into an underwriting agreement with Canaccord Genuity LLC and BTIG, LLC for the sale of 18,000,000 shares of its common stock. This agreement outlines the terms for the offering and sale of these securities to the underwriters. The company has prepared and filed a registration statement on Form S-3 with the Securities and Exchange Commission for this transaction.